Australia - English - Department of Health (Therapeutic Goods Administration)

otsuka australia pharmaceutical pty ltd - tolvaptan, quantity: 15 mg - tablet - excipient ingredients: hyprolose; magnesium stearate; microcrystalline cellulose; indigo carmine aluminium lake; lactose monohydrate; maize starch - samsca is indicated for the treatment of clinically significant hypervolemic or euvolemic hyponatremia (serum sodium less than 125 mmol/l, or less marked hyponatremia that is symptomatic and has resisted correction with fluid restriction) including patients with heart failure and syndrome of inappropriate antidiuretic hormone (siadh).

Ireland - English - HPRA (Health Products Regulatory Authority)

elanco gmbh - benazepril hydrochloride - tablet - 5 mg/tablet - benazepril

Ireland - English - HPRA (Health Products Regulatory Authority)

ecuphar nv - benazepril hydrochloride - tablet - 20 mg/tablet - benazepril

Ireland - English - HPRA (Health Products Regulatory Authority)

ecuphar nv - benazepril hydrochloride - tablet - 5 mg/tablet - benazepril

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - darifenacin hydrobromide, quantity: 17.857 mg (equivalent: darifenacin, qty 15 mg) - tablet, modified release - excipient ingredients: hypromellose; magnesium stearate; calcium hydrogen phosphate; titanium dioxide; purified talc; macrogol 4000; iron oxide yellow; iron oxide red - enablex prolonged-release tablets are indicated for the treatment of overactive bladder, with the symptoms of urgency, urge urinary incontinence or frequency of micturition.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - darifenacin hydrobromide, quantity: 8.929 mg (equivalent: darifenacin, qty 7.5 mg) - tablet, modified release - excipient ingredients: magnesium stearate; hypromellose; calcium hydrogen phosphate; titanium dioxide; purified talc; macrogol 4000 - enablex prolonged-release tablets are indicated for the treatment of overactive bladder, with the symptoms of urgency, urge urinary incontinence or frequency of micturition.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - bupropion hydrochloride, quantity: 150 mg - tablet, modified release - excipient ingredients: magnesium stearate; carnauba wax; cysteine hydrochloride; microcrystalline cellulose; hypromellose; titanium dioxide; macrogol 400; propylene glycol; purified water; isopropyl alcohol; iron oxide black - zyban sr tablets are indicated as a short-term adjunctive therapy for the treatment of nicotine dependence in those who are committed to quitting smoking, when used in conjunction with counselling for smoking cessation/abstinence.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - verapamil hydrochloride, quantity: 80 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; hypromellose; sodium lauryl sulfate; macrogol 6000; purified talc; titanium dioxide - immediate release tablets,isoptin is indicated for:,-hypertension,- angina of effort,- angina at rest,- vasospastic angina (including prinzmetal?s variant angina),- tachyarrhythmias including paroxysmal supra-ventricular tachycardia,- atrial fibrillation with rapid ventricular response,- atrial flutter with rapid ventricular response

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - verapamil hydrochloride, quantity: 40 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; hypromellose; sodium lauryl sulfate; macrogol 6000; purified talc; titanium dioxide - immediate release tablets,isoptin is indicated for:,-hypertension,- angina of effort,- angina at rest,- vasospastic angina (including prinzmetal?s variant angina),- tachyarrhythmias including paroxysmal supra-ventricular tachycardia,- atrial fibrillation with rapid ventricular response,- atrial flutter with rapid ventricular response

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - naratriptan hydrochloride, quantity: 2.78 mg (equivalent: naratriptan, qty 2.5 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; microcrystalline cellulose; lactose; titanium dioxide; hypromellose; indigo carmine; triacetin; iron oxide yellow - naramig tablets are indicated for the acute treatment of migraine attacks with or without aura.